About Zytex
Zytex is a Healthcare company based in Mumbai (India) founded in 1947. It operates as an enzymes and biotech products are manufactured for industrial applications. The company has 155 employees. Its Indian entity Zytex (India) Private Limited reported revenue of ₹52.9 Lakh. Its focus areas include Life Sciences, Nutraceuticals Tech, Supplements and Multicategory. Its competitors include Bright LifeCare, Neptune Wellness Solutions, Carson Life, Immunotec and Balchem and 4 more; 3 of its 9 listed competitors have raised funding.
Company details
Zytex was founded in 1947 and is based in Mumbai, India. Operations center on the development and production of enzymes and biotech products through chemistry and fermentation processes. These products serve sectors including textiles, baking, ethanol production, nutraceuticals, animal feed, and agriculture. Research facilities are approved by the Government of India, while manufacturing plants hold ISO, HACCP, GMP, and FAMIQS certifications.
- Headquarters Mumbai, India
- Employees 155
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website zytex.com
- Social LinkedIn
- Legal Name Zytex (India) Private Limited
- Date of Incorporation 26 Nov, 1998
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹52.9 Lakh
FY 2024 · +178% YoY
- Net Profit₹43.5 Lakh
FY 2024 · 82% margin
- EBITDA₹52.1 Lakh
FY 2024 · 98% margin
- Investors
- Employee Count155
Associated legal entities of Zytex
Zytex is associated with 3 registered companies on The Company Check; the primary company is Zytex (India) Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Zytex (India) Private Limited CIN U33110MH1998PTC117242 | Active | 26 Nov 1998 | Mumbai, Maharashtra | ₹0.5 Cr | – | 4 | View details |
| Zytex International Private Limited Zytex CIN U51397MH2006PTC160786 | Active | 28 Mar 2006 | Mumbai, Maharashtra | ₹0.0 Cr | – | 4 | View details |
| Zytex Biotech Private Limited CIN U24230MH2006PTC160565 | Active | 17 Mar 2006 | Mumbai, Maharashtra | ₹59.9 Cr | 171 | 4 | View details |
Funding Insights of Zytex
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Zytex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2007 | – | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Zytex
Zytex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Department of Biotechnology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotechnology research, guidelines, and funding by the Government of India. | 1986 | dbtindia.gov.in | Delhi, India |
Investor details for Zytex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Zytex (India) Private Limited (Zytex)
Zytex (India) Private Limited is the primary company behind Zytex. The boards of the 3 registered companies of Zytex currently have 4 directors; the longest-serving is Ashwin Mohanlal Doshi, appointed in 1998.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashwin Mohanlal Doshi DIN 00088321 | Director | 26 Nov 1998 | 27 yrs 10 mo | Zytex (India) Private Limited, Zytex Biotech Private Limited, Zytex International Private Limited Zytex |
| Dhansukh Mohanlal Doshi DIN 00088423 | Director | 26 Nov 1998 | 27 yrs 10 mo | Zytex (India) Private Limited, Zytex Biotech Private Limited, Zytex International Private Limited Zytex |
| Rashesh Dhansukh Doshi DIN 01176544 | Director | 26 Nov 1998 | 27 yrs 10 mo | Zytex (India) Private Limited, Zytex Biotech Private Limited, Zytex International Private Limited Zytex |
| Jayraj Ashwin Doshi DIN 00088486 | Director | 01 Nov 2002 | 23 yrs 11 mo | Zytex (India) Private Limited, Zytex Biotech Private Limited, Zytex International Private Limited Zytex |
Financials of Zytex
Figures of Zytex (India) Private Limited, the primary company behind Zytex, for FY 2024. Revenue was ₹52.9 Lakh (+178% year on year). Net profit was ₹43.5 Lakh (82% margin). EBITDA was ₹52.1 Lakh (98% margin). Revenue has grown at a compounded annual rate of +734% over five years.
- ₹52.9 LakhRevenue · FY 2024 · +178% YoY
- ₹43.5 LakhNet profit · 82% margin
- ₹52.1 LakhEBITDA · 98% margin
- ₹20.3 LakhPaid-up capital
- +734%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Zytex (India) Private Limited are on its company page.
Detailed financial statements for Zytex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Zytex
2 dated milestones of Zytex across 60 years, from founding to its latest funding, stage changes and deals.
- Founded Zytex is founded.
- Funding First funding round.
Competitors of Zytex
Zytex has 9 listed competitors in our database, 3 of them funded. They include Bright LifeCare, Neptune Wellness Solutions, Carson Life, Immunotec and Balchem, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| blife.in | 2011 | Gurugram, India | $170.68M | 504 | Nutritional supplements and wellness products are manufactured and sold. | |
| neptunecorp.com | 1998 | Laval, Canada | $4.5M | – | Proprietary bioactive ingredients are developed for nutraceutical and pharmaceutical uses. | |
| carsonlife.com | 2014 | Miami, United States | $5.44M | – | Natural health and beauty products are manufactured in various categories. | |
| immunotec.com | 1996 | Vaudreuil Dorion, Canada | – | – | Nutritional supplements and skin care products are manufactured and distributed. | |
| balchem.com | 1967 | New Hampton, United States | – | 2,293 | Nutraceutical ingredients are manufactured for human and animal nutrition products. | |
| meadjohnson.com | 1900 | Chicago, United States | – | 570 | Infant nutrition products are manufactured and marketed by Mead Johnson. | |
| blackmores.com.au | 1932 | Sydney, Australia | – | – | Health products for humans and animals, including vitamins, herbal and mineral nutritional supplements. | |
| lifeplan.co.uk | 1983 | Lutterworth, United Kingdom | – | 100 | Nutritional and health supplements are manufactured for various needs. | |
| synergychc.com | 2012 | Westbrook, United States | – | 36 | Health supplements and personal care products are manufactured and marketed. |
Detailed competitors of Zytex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Zytex
The website of Zytex (zytex.com) receives about 1.3K visits a month and ranks #9,998,407 among all websites worldwide, #7,820 in Biotechnology and Pharmaceuticals.
- Monthly visits1.3K
▼ 15.8% vs previous month
- Global rank#9,998,407
among all websites
- Category rank#7,820
Health · Biotechnology and Pharmaceuticals
- Bounce rate50%
- Pages per visit1.6
- Average visit31 sec
- DevicesDesktop 41% · Mobile 59%
Websites whose visitors overlap most with Zytex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| oyageninc.com | 100% | 2K | #8,401,717 | View details | |
| interhealthusa.com | 99% | – | – | View details | |
flagshipbiotech.com | flagshipbiotech.com | 62% | – | #10,435,616 | – |
| rapturebio.com | 60% | 10.9K | #2,205,064 | View details | |
| rakiro.net | 51% | 4.3K | #4,071,101 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Zytex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
10 companies that operate in the same segment as Zytex (Nutraceutical & Food-as-Medicine Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Plant-based frozen meals are delivered via weekly subscriptions. | 2016 | London, England, United Kingdom | USD 69.9 M | USD 12.54 M | 146 | |
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | – | 910 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | – | – | |
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | – | – | |
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M | – | – | |
Cellular health supplements for metabolic repair are developed and manufactured. | 2014 | New York, New York, United States | USD 66.1 M | – | – | |
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M | – | |
Low-carb products for weight loss are provided by Atkins. | 1960 | Denver, Colorado, United States | USD 15 M | – | – | |
Synbiotic supplements and fermented products for gut health are provided. | 2021 | Mumbai, Maharashtra, India | USD 20.02 M | USD 5.14 M | 88 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Zytex
Zytex was founded in 1947 and raised its 1st funding round 60 years after it was founded.
Zytex is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Zytex has 155 employees.
The primary company behind Zytex, Zytex (India) Private Limited, reported revenue of ₹52.9 Lakh for FY 2024, up 178% year on year.
Zytex was founded in 1947 and is based in Mumbai, India. Operations center on the development and production of enzymes and biotech products through chemistry and fermentation processes. These products serve sectors including textiles, baking, ethanol production, nutraceuticals, animal feed, and agriculture. Research facilities are approved by the Government of India, while manufacturing plants hold ISO, HACCP, GMP, and FAMIQS certifications.
Zytex's top competitors include Bright LifeCare, Immunotec and Mead johnson.
Zytex has 1 investor. Key investors include Department of Biotechnology.
Zytex is associated with 3 legal entities: Zytex (India) Private Limited, Zytex Biotech Private Limited, Zytex International Private Limited Zytex.
The legal entities of Zytex currently have 4 directors, including Ashwin Mohanlal Doshi, Dhansukh Mohanlal Doshi, Jayraj Ashwin Doshi and others.